Home > Insider Trading > Filing (0000947871-15-000265)

Filing Details

Accession Number:: 0000947871-15-000265
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-30 15:59:45
Reporting Period:: 2015-03-26

Filing Date:: 2015-03-30
Accepted Time:: 2015-03-30 15:59:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1270073	Intercept Pharmaceuticals Inc	ICPT	Pharmaceutical Preparations (2834)	223868459

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1171005	Jonathan Silverstein	601 Lexington Avenue, 54Th Floor New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	5,623	$281.11	1,271,901	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	8,397	$282.13	1,263,504	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	9,357	$282.87	1,254,147	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	16,845	$284.20	1,237,302	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	23,903	$285.18	1,213,399	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	7,611	$286.24	1,205,788	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	18,041	$287.16	1,187,747	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	26,028	$288.11	1,161,719	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	15,131	$289.07	1,146,588	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	13,974	$290.02	1,132,614	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	3,700	$291.12	1,128,914	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	6,000	$292.13	1,122,914	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	2,500	$293.85	1,120,414	No	4	S	Indirect	See Footnotes
Common Stock, Par Value $0.001 Per Share	Disposition	2015-03-26	90	$294.82	1,120,324	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Footnotes

The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $280.55 to $281.42 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $281.43 to $282.42 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $282.49 to $283.25 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $283.62 to $284.58 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $284.73 to $285.72 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $285.73 to $286.69 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $286.75 to $287.74 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $287.75 to $288.74 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $288.76 to $289.73 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $289.75 to $290.42 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $290.97 to $291.82 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $292.01 to $292.84 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $293.51 to $294.17 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the Shares sold at each separate price within the range set forth in this footnote.
These Shares are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV and OrbiMed Advisors LLC ("Advisors") is the managing member of GP IV. Samuel D. Isaly ("Isaly") is the managing member of and owner of a controlling interest in Advisors and may be deemed to have voting and investment power over the Shares held by OPI IV. The Reporting Person is a member of Advisors.
Each of GP IV, Advisors, Isaly and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Persons are beneficial owners for the purpose of Section 16 of the Exchange Act, or for any other purpose.